Clinical trials
Recurrence trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 5 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 29 |
| Recruiting | 18 |
| Completed | 15 |
| Terminated | 6 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 6 |
| Peking Union Medical College Hospital | 4 |
| Peking University People's Hospital | 4 |
| Nanchong Central Hospital | 3 |
| Southwest Hospital, China | 3 |
| West China Hospital | 3 |
| Donghua Zhang | 2 |
| Eastern Hepatobiliary Surgery Hospital | 2 |
| Fudan University | 2 |
| Hepatopancreatobiliary Surgery Institute of Gansu Province | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 76 |
| Carcinoma, Hepatocellular | 11 |
| Neoplasm Metastasis | 7 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma, B-Cell | 4 |
| Autoimmune Diseases | 3 |
| Hernia, Inguinal | 3 |
| Immunoglobulin G4-Related Disease | 3 |
| Leukemia | 3 |
| Ovarian Neoplasms | 3 |
Trials
Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.